Veeva Systems Change in Accounts Receivable 2012-2025 | VEEV
Veeva Systems annual/quarterly change in accounts receivable history and growth rate from 2012 to 2025. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
- Veeva Systems change in accounts receivable for the quarter ending April 30, 2025 was $0.515B, a 5.62% increase year-over-year.
- Veeva Systems change in accounts receivable for the twelve months ending April 30, 2025 was $1.417B, a 14.65% increase year-over-year.
- Veeva Systems annual change in accounts receivable for 2025 was $-0.169B, a 62.47% increase from 2024.
- Veeva Systems annual change in accounts receivable for 2024 was $-0.104B, a 14.18% increase from 2023.
- Veeva Systems annual change in accounts receivable for 2023 was $-0.091B, a 9.64% increase from 2022.
| Veeva Systems Annual Change in Accounts Receivable (Millions of US $) |
|
|---|---|
| 2025 | $-169 |
| 2024 | $-104 |
| 2023 | $-91 |
| 2022 | $-83 |
| 2021 | $-188 |
| 2020 | $-70 |
| 2019 | $-84 |
| 2018 | $-52 |
| 2017 | $-40 |
| 2016 | $-47 |
| 2015 | $-34 |
| 2014 | $-20 |
| 2013 | $-17 |
| 2012 | $-13 |
| 2011 | $-5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $45.716B | $2.747B |
| Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hims & Hers Health (HIMS) | United States | $11.427B | 94.54 |
| Doximity (DOCS) | United States | $10.997B | 48.79 |
| Tempus AI (TEM) | United States | $10.169B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $5.172B | 0.00 |
| Hinge Health (HNGE) | United States | $4.708B | 0.00 |
| Privia Health (PRVA) | United States | $2.379B | 177.36 |
| Inspire Medical Systems (INSP) | United States | $2.279B | 33.50 |
| Enovis (ENOV) | United States | $1.629B | 8.62 |
| Phreesia (PHR) | United States | $1.597B | 0.00 |
| 10x Genomics (TXG) | United States | $1.576B | 0.00 |
| Omnicell (OMCL) | United States | $1.425B | 27.46 |
| Schrodinger (SDGR) | United States | $1.421B | 0.00 |
| Azenta (AZTA) | United States | $1.335B | 58.26 |
| Evolent Health (EVH) | United States | $1.138B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.125B | 0.00 |
| Claritev (CTEV) | United States | $0.903B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.625B | 0.00 |
| Veradigm (MDRX) | United States | $0.514B | 0.00 |
| Standard BioTools (LAB) | United States | $0.490B | 0.00 |
| Talkspace (TALK) | United States | $0.413B | 123.50 |
| Zepp Health (ZEPP) | Netherlands | $0.352B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.350B | 0.00 |
| Carlsmed (CARL) | $0.322B | 0.00 | |
| TruBridge (TBRG) | United States | $0.318B | 706.33 |
| Health Catalyst (HCAT) | United States | $0.257B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.255B | 0.00 |
| Outset Medical (OM) | United States | $0.251B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.216B | 0.00 |
| CapsoVision (CV) | United States | $0.199B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.179B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.128B | 0.00 |
| American Well (AMWL) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.105B | 0.00 |
| CareCloud (CCLD) | United States | $0.105B | 4.75 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.085B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.075B | 0.00 |
| Pulmonx (LUNG) | United States | $0.066B | 0.00 |
| 111 (YI) | China | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.032B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.018B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |